000 | 01783 a2200505 4500 | ||
---|---|---|---|
005 | 20250515224140.0 | ||
264 | 0 | _c20101020 | |
008 | 201010s 0 0 eng d | ||
022 | _a1525-5069 | ||
024 | 7 |
_a10.1016/j.yebeh.2010.04.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Qi-Xin | |
245 | 0 | 0 |
_aStress within the postseizure time window inhibits seizure recurrence. _h[electronic resource] |
260 |
_bEpilepsy & behavior : E&B _cJul 2010 |
||
300 |
_a201-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
650 | 0 | 4 |
_aCorticosterone _xadministration & dosage |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aHormone Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aKindling, Neurologic _xdrug effects |
650 | 0 | 4 |
_aMifepristone _xtherapeutic use |
650 | 0 | 4 |
_aPentylenetetrazole _xadverse effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSecondary Prevention |
650 | 0 | 4 |
_aSeizures _xchemically induced |
650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
650 | 0 | 4 |
_aStress, Physiological _xphysiology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aMao, Rong-Rong | |
700 | 1 | _aDuan, Ting-Ting | |
700 | 1 | _aTan, Ji-Wei | |
700 | 1 | _aTian, Meng | |
700 | 1 | _aCao, Jun | |
700 | 1 | _aXu, Lin | |
773 | 0 |
_tEpilepsy & behavior : E&B _gvol. 18 _gno. 3 _gp. 201-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yebeh.2010.04.007 _zAvailable from publisher's website |
999 |
_c19846875 _d19846875 |